Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In Q1 2023 – Tesla, Apple, AMC, DWAC And More
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.